Ironstone Group Inc (IRNS)

[db7]

from 10Q:

"


3. INVESTMENTS



TangoMe, Inc.



On March 30, 2012, the Company purchased 468,121 shares of Series A Preferred stock from related party William R. Hambrecht at $2.14 per share, resulting in a total investment of $1,000,000. For the year ended December 31, 2020 there was no valuation gain or loss for TangoMe, Inc., remaining at a valuation of $2,574,666. There was no change in value as of March 31, 2021, with the valuation remaining at $2,574,666. The investment fair value is based on using an average company valuation for TangoMe Inc. as determined by the “MESE” big data analysis system and SPAC inquiries for TangoMe, Inc. These are the primary significant unobservable input used in the fair value measurement of the Company’s investment.

"

"
Arcimoto, Inc.



During fiscal year 2014 the Company purchased 37,000 shares of Arcimoto, Inc. series A-1 preferred stock for $100,011. The A-1 preferred stock was converted to common stock during 2017 prior to Arcimoto filing for its initial public offering. On October 2, 2015 the Ironstone Group, Inc. was granted 2,500 Arcimoto options, strike price $4.121 per share, expiration October 2, 2025. During 2017, there was a 2 for 1 stock split, increasing the options held to 5,000 with a $2.0605 strike price per share. On September 17, 2017, Arcimoto listed on Nasdaq. The closing price on December 31, 2020 was $13.23 per share, resulting in a stock holdings valuation of $489,510 and in-the-money options valuation of $55,848. On March 31, 2021 the closing price was also $13.23 per share, maintaining the stock holding valuation of $489,510 and options in-the-money valuation of $55,848, resulting in no gain or loss for the quarter ended March 31, 2021.



Buoy Health, Inc.



On March 17, 2021 the Company purchased 11,233 common shares of the private company Buoy Health, Inc. at $15.92 per share. The total value of the investment was $178,824 at March 31, 2021.


"